Tag: lexaria bioscience corp
October 8, 2019
Lexaria Bioscience Provides Update on R&D Program Progress under License Agreement with Altria
Lexaria is pleased to provide this update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine...
October 2, 2019
Smart Cannabis Vaporizers Empowering Physicians and Patients
Without accurate and reliable dosing, medical cannabis won’t make the pharmaceutical grade. August 27, 2019
Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions
Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce... August 21, 2019
Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil
Lexaria Bioscience Corp. (OTC:LXRP, CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce... August 15, 2019
Lexaria Bioscience Announces it has Received Four New Patents
Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce... August 14, 2019
Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors
Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce... August 13, 2019